Applied Biocode Corporation Announces Revenue Results for the Fourth Quarter and Full Year of 2022
For the year, the company reported revenue of $13 million, which marks 13% growth year over year.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.9 TWD | -0.75% | -0.50% | -21.34% |
15/04 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
21/03 | Applied BioCode Announces CEO Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-21.34% | 50.18M | |
-24.86% | 10.26B | |
-11.28% | 2.94B | |
-12.92% | 2.19B | |
-18.21% | 1.72B | |
+60.76% | 1.4B | |
+24.83% | 780M | |
-4.59% | 736M | |
-22.45% | 560M | |
-0.60% | 293M |